Han Cong

Post-investment management, civil and commercial dispute resolution, corporate governance, and other related legal services

July 2014 to October 2015 Jiangsu Hongyuan Law Firm
November 2015 – present Jiangsu JC Master Law Offices

1. Attorney Han Cong primarily provides legal services in areas such as post-investment fund management, civil and commercial dispute resolution, and corporate governance, with extensive experience in these fields. He has represented investment institutions including Yida Capital, Lianquan Guoxin, Nan Venture Capital, Qilin Venture Capital, Xi Venture Capital, Jinyu Maowu, Shanghai Zhonghuijin, and others, handling their investment exit matters and achieving favorable outcomes.
2. Representative cases handled by Attorney Han Cong include, but are not limited to: the equity repurchase dispute between Jiangsu GaoTou Ningtai Venture Investment Partnership (Limited Partnership) and Lianyungang Guanyun Renji Hospital, among others; the equity repurchase dispute between Jiangsu Talent Innovation and Entrepreneurship Investment Partnership (Limited Partnership) and Li Nanjie, among others; the equity repurchase dispute between Nanjing Industrial Development Fund Co., Ltd. and Shen Meng, among others; a series of equity repurchase disputes involving JinYu Maowu Investment Management Co., Ltd. and Jiangsu Sanxi Technology Co., Ltd., among others; the equity repurchase dispute between Nanjing Chuangyi Haohui Venture Investment Partnership (Limited Partnership) and Zhang Chi, among others; the equity repurchase dispute between Nanjing Chuangyi Haohui Venture Investment Partnership (Limited Partnership) and Zhao Wei, among others; the equity repurchase dispute between Wuxi Hechuang High-Tech Phase II Equity Investment Partnership (Limited Partnership) and Qin Jiayi, among others; the equity repurchase dispute between Nanjing Qilin High-Tech Zone Venture Investment Fund Partnership (Limited Partnership) and Zhang Liang, among others; the equity repurchase dispute between Jiangsu SME Development Fund (Limited Partnership) and Liu Shunlong, among others; the equity repurchase dispute between Jiangsu Yida M&A Growth Equity Investment Fund (Limited Partnership) and Shi Jijun, among others; the equity repurchase dispute between Suzhou Yida Innovation and Entrepreneurship Investment Partnership (Limited Partnership) and Shi Jijun, among others; the equity repurchase dispute between Jiangsu Jianquan Guoxin New Energy Industry Investment Fund Partnership (Limited Partnership) and Kang Yong, among others; the equity repurchase dispute between Nanjing Qinhuai Industrial Guidance Fund Partnership (Limited Partnership) and Fu Jianling, among others; the equity repurchase dispute between Nanjing Jiangbei Medical Innovation Industry Fund (Limited Partnership) and Zhou Liang, among others; the equity repurchase dispute between Kunshan Fumao Venture Investment Partnership (Limited Partnership) and Zhang Jingbin, among others; the equity repurchase dispute between Jiangsu New Materials Industry Venture Investment Enterprise (Limited Partnership) and Jiang Wenxian, among others; the equity repurchase dispute between Tibet Jinmao Economic and Information Venture Investment Co., Ltd. and Zhang Liping, among others; the equity repurchase dispute between Nanjing Jintou Health Industry Investment Enterprise (Limited Partnership) and Zhu Mingfei, among others; the equity repurchase dispute between Wuxi Jinmao Huishan Medical and Health Industry Investment Partnership (Limited Partnership) and Deng Xiaoming, among others; the equity repurchase dispute between Taicang Jinmao Biopharmaceutical Venture Investment Enterprise (Limited Partnership) and He Aimin, among others; the equity repurchase dispute between Jiangsu Jianquan Jinmao New Materials Venture Investment Partnership (Limited Partnership) and Zhuang Ming, among others; the equity repurchase dispute between Jiangsu New Materials Industry Venture Investment Enterprise (Limited Partnership) and Chen Long, among others; the equity repurchase dispute between Jiangsu Jinmao Low-Carbon Industry Venture Investment Co., Ltd. and Pan Dekou, among others; a series of performance compensation disputes involving Jinling Pharmaceutical Co., Ltd. and Huzhou Guoxin Materials Co., Ltd., among others; the performance compensation dispute between Wang Junxia and Fujian Adier Jewelry Industrial Co., Ltd.; and the share‑custody dispute involving Wuxi Kewenning Trading Co., Ltd. and Jiangsu Zhongmei Mining Equipment Co., Ltd., among other listed companies.
3. Attorney Han Cong currently serves as the long-term legal counsel to numerous enterprises, including Jinling Pharmaceutical Co., Ltd., Jiangsu Phoenix Xinhua Printing Group Co., Ltd., Baosheng Technology Innovation Co., Ltd., Jiangsu Xinguanglian Optoelectronics Co., Ltd., Jiangsu Xinguanglian Technology Co., Ltd., and Jinyu Maowu Investment Management Co., Ltd.